<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:mp ids='MP_0002038'>Carcinoma</z:mp> of the gastroesophageal junction (GEJ) is defined as <z:mp ids='MP_0002038'>carcinoma</z:mp> that crosses the GEJ line, irrespective of where the <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> epicenter is located </plain></SENT>
<SENT sid="1" pm="."><plain>This group of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> is rare but controversial </plain></SENT>
<SENT sid="2" pm="."><plain>Based on study results from the majority of epidemiologic and clinicopathologic investigations carried out in Western countries, this <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> is believed to arise from <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> (BE) and includes both distal esophageal and proximal gastric <z:mp ids='MP_0002038'>carcinomas</z:mp> because of similar characteristics in epidemiology, clinicopathology, and molecular pathobiology in relation to BE </plain></SENT>
<SENT sid="3" pm="."><plain>As such, the most recent American Joint Committee on <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">Cancer</z:e> staging manual requires staging <z:hpo ids='HP_0000001'>all</z:hpo> GEJ <z:mp ids='MP_0002038'>carcinomas</z:mp> with the rule for esophageal <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> (EA) </plain></SENT>
<SENT sid="4" pm="."><plain>This mandate has been challenged recently by the data from several studies carried out mainly in Chinese patients </plain></SENT>
<SENT sid="5" pm="."><plain>The emerging evidence derived from those studies suggests: (1) both BE and EA are uncommon in the Chinese population; (2) almost <z:hpo ids='HP_0000001'>all</z:hpo> GEJ <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> in Chinese arise in the proximal stomach and show the features of proximal <z:hpo ids='HP_0012126'>gastric cancer</z:hpo>, not those of EA; (3) application of the new <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> staging rule to GEJ <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> of Chinese patients cannot stratify patients' prognosis effectively; and (4) prognostic factors of GEJ <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> in Chinese are similar, but not identical, to those of EA </plain></SENT>
<SENT sid="6" pm="."><plain>In conclusion, the recent evidence suggests that GEJ <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> in Chinese shows distinct clinicopathologic characteristics that are different from EA </plain></SENT>
<SENT sid="7" pm="."><plain>Further investigations in molecular pathology may help illustrate the underlying pathogenesis mechanisms of this <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> in Chinese patients and better manage patients with this fatal disease </plain></SENT>
</text></document>